His lab uses comparative transcriptomics and functional assays in model organisms to investigate the evolution of alternative splicing and its impact in complex polygenic human diseases, such as diabetes and autism.
Her lab investigates host/microbiome interactions with a focus on host genetic effects on the gut microbiome and the role of microbial transfers between social partners.
His lab interrogates genome diversity to infer what are the forces that affect living organisms, how and when they act and how they affect biodiversity, human emotions or the differential susceptibility of different people to certain diseases.
His lab uses and develops single-cell omics methods to investigate the evolution of cell types in animals. He is co-coordinating the Biodiversity Cell Atlas (BCA) with the EBI-EMBL.
His team employs state-of-the-art genome sequencing in conjunction with functional multi-omics data to investigate the impact of repetitive DNA on genome function, evolution and disease.
His lab analyzes human genome diversity with the aim of inferring the genomic and population processes that are responsible for this diversity, and outlining the population and epidemiological consequences of the human genetic variability.
Her lab focuses on cancer as an evolutionary system. She is interested in different modes of selection active during tumorigenesis, happening in the coding or the non-coding part of the genome.
Her lab focuses on investigating human genomic diversity. They are particularly interested in the architecture of the genetic predisposition to complex disease and in human adaptive traits that have undergone positive selection during human evolution.
His lab is interested in human genomic diversity and how it relates to social and cultural aspects (ethnicity, surnames), to demographic history, or the natural history of human diseases, as well as its applications in forensic genetics.
His lab focuses on understanding changes in genome regulation that lead to monogenic and polygenic diabetes, and on developing strategies to correct these changes in human patients.
Her lab uses comparative transcriptomic, epitrancriptomics and translatomics to study how mosquito-borne viruses, such as dengue or zika viruses, efficiently translate and replicate their genomes in mosquitoes and humans, two hosts separated by one billion years in evolution.
Their lab develops machine learning methods to predict the effect of genomic variation on phenotype, with an emphasis on research that will directly impact the diagnostic yield of patient sequencing.
His lab uses artificial evolution and ancestral evolutionary reconstructions to create new systems to enable more efficient and secure modification of the human genome and metagenome, as well as to create new biological functions with biotechnological relevance.
Our research focuses on the role of the human microbiome in mental health and the social transmission of the microbiome.
Her lab studies different aspects of human genome variation, population genetics, and disease susceptibility in the past and present Native American and Latin American populations.
PRBB Building
Dr. Aiguader, 88
08003 Barcelona | Spain
https://orcid.org/0000-0002-2179-2567
